Bio-Techne Corp
NASDAQ:TECH

Watchlist Manager
Bio-Techne Corp Logo
Bio-Techne Corp
NASDAQ:TECH
Watchlist
Price: 63.51 USD -1.99% Market Closed
Market Cap: $9.9B

During the last 3 months Bio-Techne Corp insiders have not bought any shares, and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Aug 25, 2025 by Baumgartner Robert V , who sold 957.8k USD worth of TECH shares.

Last Transactions:
Nusse Roeland
$-960.4k
Baumgartner Robert V
$-957.8k
Herr Amy E.
$-63.7k
Herr Amy E.
$-122.7k
Kelderman Kim
$-905.5k
Baumgartner Robert V
$-1.2m
Higgins John L
$-335.4k
Nusse Roeland
$-800.6k
Nusse Roeland
$-718k
Kummeth Charles R.
$-7.1m
Kummeth Charles R.
$-26.7k
Furlow Brenda S.
$-611.8k
Furlow Brenda S.
$-65.6k
Higgins John L
$-3.1m
Higgins John L
$-5.4m
Higgins John L
$-3.5m
Higgins John L
$-5.8m
Kummeth Charles R.
$-29.8m
Baumgartner Robert V
$+1.7m
Kelderman Kim
$-806k
Eansor Norman David
$-5.6m
Hippel James
$-1.7m
Hippel James
$-30m
Hippel James
$-5.6m
Hippel James
$-840.3k
Kelderman Kim
$-7m
Steer Randolph C
$-23.6m
Hippel James
$-81.1m
Furlow Brenda S.
$-43.2m
Eansor Norman David
$-12.4m
Furlow Brenda S.
$-2.6m
Nusse Roeland
$-30.8m
View All Transactions

During the last 3 months Bio-Techne Corp insiders have not bought any shares, and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).

The last transaction was made on Aug 25, 2025 by Baumgartner Robert V , who sold 957.8k USD worth of TECH shares.

Sold
0-3
months
0 USD
0
3-6
months
1.9m USD
2
6-9
months
63.7k USD
1
9-12
months
122.7k USD
1
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Bio-Techne Corp
Insider Trading Chart

Bio-Techne Corp
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Bio-Techne Corp
Last Insider Transactions

Global
Insiders Monitor

Bio-Techne Corp
Glance View

Bio-Techne Corp. began its journey with a clear focus: to bridge the gap between biological research and practical applications, a mission that it continues to pursue with zeal. At its core, Bio-Techne operates as a pioneer in the production and distribution of biotechnology products, catering to the needs of the scientific community across the globe. The company specializes in providing essential tools for life sciences research, including proteins, antibodies, and reagents, empowering researchers to explore and innovate in fields ranging from cancer biology to neuroscience. These offerings are developed with meticulous care and a deep understanding of the scientific process, which positions Bio-Techne as a trusted ally to laboratories and research institutions worldwide. The financial heartbeat of Bio-Techne lies in its diverse portfolio, which extends into clinical diagnostics and genomics, segments that are critical in an era of personalized medicine and rapid technological advancement in healthcare. The company's revenue streams are robust, driven by a strategic blend of direct sales and collaborations with major pharmaceutical and biotech companies. Furthermore, Bio-Techne smartly leverages its acquisitions to fortify its market position, enhancing its capabilities and expanding its product lines. This agility and foresight not only enable Bio-Techne to sustain its growth trajectory but also to continually meet the ever-evolving demands of a fast-paced, innovation-driven industry.

TECH Intrinsic Value
HIDDEN
Show

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top